Sipra Surgi-Med Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -20.30%
(FY 2020)
- Profit 39.36%
(FY 2020)
- Ebitda 160.86%
(FY 2020)
- Net Worth 45.64%
(FY 2020)
- Total Assets 111.12%
(FY 2020)
About Sipra Surgi-Med
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narayanappa Udayakumar and Srinidhi Narasimhamurthy serve as directors at the Company.
- CIN/LLPIN
U52100KA2017PTC105707
- Company No.
105707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sipra Surgi-Med Private Limited offer?
Sipra Surgi-Med Private Limited offers a wide range of products and services, including Orthopedic Equipment & Supplies, Orthopedic Instruments, Medical & Surgical Clothing, Hospital Linen, OT Linen, Urological & Obstetrics Instruments, Urology Equipment, Cushion & Cushion Covers, Pillow Covers.
Who are the key members and board of directors at Sipra Surgi-Med?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayanappa Udayakumar  | Additional Director | 31-Aug-2023 | Current |
| Srinidhi Narasimhamurthy | Director | 21-Aug-2017 | Current |
Financial Performance of Sipra Surgi-Med.
Sipra Surgi-Med Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 20.3% decrease. The company also saw a substantial improvement in profitability, with a 39.36% increase in profit. The company's net worth Soared by an impressive increase of 45.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sipra Surgi-Med?
In 2020, Sipra Surgi-Med had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sipra Surgi-Med?
Sipra Surgi-Med has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sipra Surgi-Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sipra Surgi-Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
